Calidi Biotherapeutics, Inc. (CLDI)
1.12
+0.02
(+1.82%)
USD |
NYAM |
Sep 21, 16:00
1.18
+0.06
(+5.36%)
After-Hours: 20:00
Calidi Biotherapeutics Total Assets (Quarterly) : 7.204M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.204M |
| March 31, 2026 | 9.591M |
| December 31, 2025 | 8.857M |
| September 30, 2025 | 14.03M |
| June 30, 2025 | 9.351M |
| March 31, 2025 | 15.06M |
| December 31, 2024 | 14.18M |
| September 30, 2024 | 6.657M |
| June 30, 2024 | 6.431M |
| March 31, 2024 | 7.405M |
| December 31, 2023 | 10.02M |
| Date | Value |
|---|---|
| September 30, 2023 | 18.59M |
| June 30, 2023 | 44.01M |
| March 31, 2023 | 43.18M |
| December 31, 2022 | 2.597M |
| September 30, 2022 | 42.16M |
| June 30, 2022 | 231.02M |
| March 31, 2022 | 231.24M |
| December 31, 2021 | 231.77M |
| September 30, 2021 | 232.01M |
| June 30, 2021 | 0.6249M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.071M |
| Shareholders Equity (Quarterly) | 3.133M |
| Debt to Equity Ratio | 0.6199 |
| Current Ratio | 1.677 |
| Net Debt Paydown Yield | 9.76% |